Omnicell Inc
NASDAQ:OMCL

Watchlist Manager
Omnicell Inc Logo
Omnicell Inc
NASDAQ:OMCL
Watchlist
Price: 44.5 USD -1.07%
Market Cap: 2.1B USD
Have any thoughts about
Omnicell Inc?
Write Note

Omnicell Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Omnicell Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Omnicell Inc
NASDAQ:OMCL
Accrued Liabilities
$177.6m
CAGR 3-Years
9%
CAGR 5-Years
16%
CAGR 10-Years
23%
Veeva Systems Inc
NYSE:VEEV
Accrued Liabilities
$74.7m
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
14%
Inspire Medical Systems Inc
NYSE:INSP
Accrued Liabilities
$37.5m
CAGR 3-Years
29%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Accrued Liabilities
$25.9m
CAGR 3-Years
14%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Certara Inc
NASDAQ:CERT
Accrued Liabilities
$41.7m
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Accrued Liabilities
$29.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Omnicell Inc
Glance View

Market Cap
2.1B USD
Industry
Health Care

Omnicell Inc. stands at the intersection of healthcare and technology, sculpting the landscape of medication management systems with its innovative spirit. Founded in 1992, Omnicell has evolved from a small enterprise into a leading provider of automated solutions for medication and supply dispensing, inventory management, and analytics. The company’s core offering, its automated dispensing systems, reshapes how hospitals, pharmacies, and healthcare providers manage medications. By utilizing cutting-edge technology, Omnicell improves efficiency, reduces medication errors, and cuts down on healthcare costs. These systems are embedded in the workflow of healthcare facilities, ensuring that medication management becomes seamless, thus elevating patient safety and clinical outcomes. Revenue streams flow robustly from both product sales and associated services. Omnicell garners income by selling its advanced hardware systems, which include everything from pharmacy carousels to medication robotic systems, and supplements these sales with software solutions that offer predictive analytics and inventory optimization. Beyond the initial sale, a significant part of their business model includes recurring revenue through service contracts, software updates, and customer support. This dual approach not only ensures a steady cash flow but also strengthens customer relationships by consistently providing value over time. As the healthcare industry increasingly leans on technology for streamlined operations and cost management, Omnicell’s strategic positioning allows it to capitalize on the demand for sophisticated medication management solutions.

OMCL Intrinsic Value
52.73 USD
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Omnicell Inc's Accrued Liabilities?
Accrued Liabilities
177.6m USD

Based on the financial report for Sep 30, 2024, Omnicell Inc's Accrued Liabilities amounts to 177.6m USD.

What is Omnicell Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
23%

Over the last year, the Accrued Liabilities growth was 5%. The average annual Accrued Liabilities growth rates for Omnicell Inc have been 9% over the past three years , 16% over the past five years , and 23% over the past ten years .

Back to Top